Findell Capital Management as of Dec. 31, 2025
Portfolio Holdings for Findell Capital Management
Findell Capital Management holds 15 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Liquidia Corporation Com New (LQDA) | 41.7 | $145M | 4.2M | 34.49 | |
| Establishment Labs Holdings Ord (ESTA) | 23.7 | $82M | 1.1M | 72.88 | |
| Root Cl A New (ROOT) | 4.9 | $17M | 235k | 72.23 | |
| Dave Class A Com New (DAVE) | 4.5 | $16M | 70k | 221.41 | |
| Turning Pt Brands (TPB) | 4.0 | $14M | 127k | 108.40 | |
| Oportun Finl Corp (OPRT) | 3.9 | $14M | 2.6M | 5.29 | |
| Super Group Sghc Ord Shs (SGHC) | 3.2 | $11M | 940k | 11.95 | |
| Geo Group Inc/the reit (GEO) | 3.0 | $11M | 650k | 16.12 | |
| Celsius Hldgs Com New (CELH) | 2.8 | $9.6M | 210k | 45.74 | |
| eHealth (EHTH) | 1.9 | $6.5M | 1.4M | 4.60 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.9 | $6.5M | 48k | 134.85 | |
| Stride (LRN) | 1.7 | $5.8M | 90k | 64.93 | |
| Adma Biologics (ADMA) | 1.6 | $5.5M | 300k | 18.24 | |
| Vor Biopharma Com New (VOR) | 0.9 | $3.0M | 231k | 13.08 | |
| Mineralys Therapeutics (MLYS) | 0.5 | $1.8M | 50k | 36.29 |
